Serdexmethylphenidate/dexmethylphenidate - Zevra Therapeutics
At a glance
- Drug Originator KemPharm
- Drug Licenced by Ark Biosciences; Gurnet point capital
- Drug Class Amines; Behavioural disorder therapies; Drug withdrawal therapies; Ethers; Phenylacetates; Piperidines; Pyridines; Sleep disorder therapies; Small molecules
- Mechanism of Action Adrenergic receptor modulators; Central nervous system stimulants; Dopamine release stimulants
- USA Patent Applicants COMMAVE THERAP
- USA Patents 12
- NDAs 1
- International Patents 83
Disclaimer